Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts

World Journal of Surgery

Volumn 31, Issue 5, 2007, Pages 888-894

  Miccoli, Paolo ^a   Minuto, Michele N ^a   Ugolini, Clara ^a   Panicucci, Erica ^a   Berti, Piero ^a   Massi, Marco ^a   Basolo, Fulvio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILATERAL CANCER; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; STATISTICAL ANALYSIS; THYROID CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; CARCINOMA, PAPILLARY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 34248201221     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0795-9     Document Type: Article

References (27)

1. Loh KC, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:353-362.
2. Katoh R, Sasaki J, Kurihara H, et al. Multiple thyroid involvement (intraglandular metastases) in papillary thyroid carcinoma: a clinicopathological study of 105 consecutive patients. Cancer 1992;70:1585-1590.
3. Silverberg SG, Hutter RVP, Foote FW Jr. Fatal carcinoma of the thyroid: histology, metastases and causes of death. Cancer 1970;25:792-802.
4. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-966.
5. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11:877-881.
6. Shaha A, Shah J, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 1997;4:328-333.
7. Cady B. Papillary carcinoma of the thyroid gland: treatment based on risk-group definition. Surg Oncol Clin N Am 1998;7:633-644.
8. Wanebo H, Coburn M, Teates D, et al. Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg 1998;227:912-921.
9. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 2005;12:81-89.
10. Passler C, Scheuba C, Asari R, et al. Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 2005;92:184-189.
11. Dobert N, Menzel C, Oeschger S, et al. Differentiated thyroid carcinoma: the new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients. Thyroid 2004;14:65-70.
12. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95:(Suppl) 2-4.
13. Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154-168.
14. Miccoli P, Minuto MN, Galleri D, et al. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg 2006;76:123-126.
15. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer; American Thyroid Association. Arch Intern Med 1996;156:2165-2172.
16. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma; American Association of Clinical Endocrinologists, American College of Endocrinology. Endocr Pract 2001;7:202-220.
17. Mazzaferri EL. Thyroid carcinoma practice guidelines. Oncology 1999;13(Suppl 11A):391-442.
18. Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 1988;12:22-27.
19. Terry JH, St. John SA, Karkowski FJ, et al. Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg 1994;168:459-461.
20. Filie AC, Chiesa A, Bryant BR, et al. The tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer 1999;87:238-242.
21. Paessler M, Kreisel FH, LiVolsi VA, et al. Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma? Int J Surg Pathol 2002;10:267-272.
22. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004;114:393-402.
23. Yildirim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005;200:378-392.
24. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
25. Kim ES, Kim TY, Kim YI, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) 2004;61:145-148.
26. Gemsenjager E, Heitz PU, Martina B. Selective treatment of differentiated thyroid carcinoma. World J Surg 1997;21:546-551;discussion 551-552.
27. Pellegriti G, Scollo C, Lumera G, et al. Clinical behaviour and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004;89:3713-3720.